Vazquez Guillamet C[au] - Search Results

Year	Number of Results
2014	4
2015	1
2018	3
2021	2
2022	1
2023	0

1

Pulmonary Infections in Immunocompromised Hosts: Clinical.

Vazquez Guillamet C, Hsu JL, Dhillon G, Vazquez Guillamet R. Vazquez Guillamet C, et al. J Thorac Imaging. 2018 Sep;33(5):295-305. doi: 10.1097/RTI.0000000000000351. J Thorac Imaging. 2018. PMID: 30048345 Free PMC article. Review.

2

Understanding Decision Making in Critical Care.

Lighthall GK, Vazquez-Guillamet C. Lighthall GK, et al. Among authors: vazquez guillamet c. Clin Med Res. 2015 Dec;13(3-4):156-68. doi: 10.3121/cmr.2015.1289. Epub 2015 Sep 20. Clin Med Res. 2015. PMID: 26387708 Free PMC article. Review.

3

Acinetobacter Pneumonia: Improving Outcomes With Early Identification and Appropriate Therapy.

Vazquez Guillamet C, Kollef MH. Vazquez Guillamet C, et al. Clin Infect Dis. 2018 Oct 15;67(9):1455-1462. doi: 10.1093/cid/ciy375. Clin Infect Dis. 2018. PMID: 29741597 Review.

4

Is Zero Ventilator-Associated Pneumonia Achievable?: Practical Approaches to Ventilator-Associated Pneumonia Prevention.

Vazquez Guillamet C, Kollef MH. Vazquez Guillamet C, et al. Clin Chest Med. 2018 Dec;39(4):809-822. doi: 10.1016/j.ccm.2018.08.004. Clin Chest Med. 2018. PMID: 30390751 Review.

5

Treatment of Gram-positive infections in critically ill patients.

Vazquez-Guillamet C, Kollef MH. Vazquez-Guillamet C, et al. BMC Infect Dis. 2014 Nov 28;14:92. doi: 10.1186/1471-2334-14-92. BMC Infect Dis. 2014. PMID: 25431211 Free PMC article. Review.

6

The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic.

Reynolds D, Burnham JP, Vazquez Guillamet C, McCabe M, Yuenger V, Betthauser K, Micek ST, Kollef MH. Reynolds D, et al. Among authors: vazquez guillamet c. Eur Respir Rev. 2022 Oct 19;31(166):220068. doi: 10.1183/16000617.0068-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36261159 Free PMC article.

7

The Clinical Course of Coronavirus Disease 2019 in a US Hospital System: A Multistate Analysis.

Mody A, Lyons PG, Vazquez Guillamet C, Michelson A, Yu S, Namwase AS, Sinha P, Powderly WG, Woeltje K, Geng EH. Mody A, et al. Among authors: vazquez guillamet c. Am J Epidemiol. 2021 Apr 6;190(4):539-552. doi: 10.1093/aje/kwaa286. Am J Epidemiol. 2021. PMID: 33351077 Free PMC article.

8

Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.

Reynolds D, Vazquez Guillamet C, Day A, Borcherding N, Vazquez Guillamet R, Choreño-Parra JA, House SL, O'Halloran JA, Zúñiga J, Ellebedy AH, Byers DE, Mudd PA. Reynolds D, et al. Among authors: vazquez guillamet c. J Immunol. 2021 Sep 1;207(5):1229-1238. doi: 10.4049/jimmunol.2100294. Epub 2021 Aug 4. J Immunol. 2021. PMID: 34348975 Free PMC article.

9

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.

Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH. Zilberberg MD, et al. Among authors: vazquez guillamet c. Crit Care. 2014 Nov 21;18(6):596. doi: 10.1186/s13054-014-0596-8. Crit Care. 2014. PMID: 25412897 Free PMC article.

10

Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.

Vazquez-Guillamet C, Scolari M, Zilberberg MD, Shorr AF, Micek ST, Kollef M. Vazquez-Guillamet C, et al. Crit Care Med. 2014 Nov;42(11):2342-9. doi: 10.1097/CCM.0000000000000516. Crit Care Med. 2014. PMID: 25072764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results